An Efficient Approach to Chiral C8/C9-Piperazino-Substituted 1,4-Benzodiazepin-2-ones as Peptidomimetic Scaffolds

被引:23
作者
Butini, Stefania [1 ,2 ]
Gabellieri, Emanuele [1 ,2 ]
Huleatt, Paul Brady [1 ,2 ]
Campiani, Giuseppe [1 ,2 ]
Franceschini, Silvia [1 ,2 ]
Brindisi, Margherita [1 ,2 ]
Ros, Sindu [1 ,2 ]
Coccone, Salvatore Sanna [1 ,2 ]
Fiorini, Isabella [1 ,2 ]
Novellino, Ettore [1 ,3 ]
Giorgi, Gianluca [4 ]
Gemma, Sandra [1 ,2 ]
机构
[1] Univ Siena, European Res Ctr Drug Discovery & Dev NatSynDrugs, I-53100 Siena, Italy
[2] Univ Siena, DFCT, I-53100 Siena, Italy
[3] Univ Naples Federico 2, DCF&T, I-80131 Naples, Italy
[4] Univ Siena, Dipartimento Chim, I-53100 Siena, Italy
关键词
D O I
10.1021/jo8015456
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A promising way to interfere with biological processes is through the modulation of protein-protein interactions by rneans of small molecules acting as peptidomimetics. The 1,4-benzodiazepine scaffold c has been widely reported as a peptide-mimicking, pharmacogenic system. While several synthetic pathways to C6-8 substituted benzodiazepines have been disclosed, few 1,4-benzodiazepines substituted at C9 have been reported. Herein, we describe a versatile approach to introduce cyclic, protonatable functionality at C8/C9. Introduction of the piperazine system at C8 and C9 gave access to a unique functionalization of the versatile benzodiazepine skeleton, broadening tailoring options on the benzofused side of the molecule, and the possibility of discovering novel peptidomimetics potentially able to modulate protein-protein interactions. Coupling of activated amino acids with poorly reactive anilines under mild conditions, while avoiding racemization, gave easy access to these compounds. Efficient amino acid activation was obtained by exploiting the rapid formation of acid chlorides under low temperature and acid/base free conditions, using triphenylphosphine and hexachloroacetone. This procedure successfully resulted in high reaction yields, did not produce racemization (ee > 98%, as demonstrated by using chiral solvating agents), and was compatible with the acid sensitive protecting groups present in the substrates.
引用
收藏
页码:8458 / 8468
页数:11
相关论文
共 62 条
[1]   5-fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985):: An orally active arginine vasopressin antagonist with selectivity for V2 receptors [J].
Albright, JD ;
Reich, MF ;
Delos Santos, EG ;
Dusza, JP ;
Sum, FW ;
Venkatesan, AM ;
Coupet, J ;
Chan, PS ;
Ru, X ;
Mazandarani, H ;
Bailey, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (14) :2442-2444
[2]   Protein-protein interactions as a target for drugs in proteomics [J].
Archakov, AI ;
Govorun, VM ;
Dubanov, AV ;
Ivanov, YD ;
Veselovsky, AV ;
Lewi, P ;
Janssen, P .
PROTEOMICS, 2003, 3 (04) :380-391
[3]   Anatomy of hot spots in protein interfaces [J].
Bogan, AA ;
Thorn, KS .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (01) :1-9
[4]   Peptide synthesis via amino acid halides [J].
Carpino, LA ;
Beyermann, M ;
Wenschuh, H ;
Bienert, M .
ACCOUNTS OF CHEMICAL RESEARCH, 1996, 29 (06) :268-274
[5]   1,4-Benzodiazepines as inhibitors of respiratory syncytial virus [J].
Carter, MC ;
Alber, DG ;
Baxter, RC ;
Bithell, SK ;
Budworth, J ;
Chubb, A ;
Cockerill, GS ;
Dowdell, VCL ;
Henderson, EA ;
Keegan, SJ ;
Kelsey, RD ;
Lockyer, MJ ;
Stables, JN ;
Wilson, LJ ;
Powell, KL .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (07) :2311-2319
[6]   A HOT-SPOT OF BINDING-ENERGY IN A HORMONE-RECEPTOR INTERFACE [J].
CLACKSON, T ;
WELLS, JA .
SCIENCE, 1995, 267 (5196) :383-386
[7]   Protein-protein interfaces: mimics and inhibitors [J].
Cochran, AG .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (06) :654-659
[8]   Substituted 1,4-benzodiazepine-2,5-diones as α-helix mimetic antagonists of the HDM2-p53 protein-protein interaction [J].
Cummings, MD ;
Schubert, C ;
Parks, DJ ;
Calvo, RR ;
LaFrance, LV ;
Lattanze, J ;
Milkiewicz, KL ;
Lu, TB .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (03) :201-205
[9]   Bartoli indole synthesis [J].
Dalpozzo, R ;
Bartoli, G .
CURRENT ORGANIC CHEMISTRY, 2005, 9 (02) :163-178
[10]  
Davidson JRT, 2001, J CLIN PSYCHIAT, V62, P46